Company: TYRA
Filing Date: 2025-04-18
Form Type: DEF 14A
Source: 0001193125-25-085709
Chunk: 30

Company: Tyra Biosciences, Inc.
Filing Date: 2025-04-18
Form: DEF 14A
Chunk 30
---
 |                      |   |     |            | X |
| Jake Simson, Ph.D.                 |     |       |   |   |     |              |   |     |                      | X |     |            | C |
| Rehan Verjee                       |     |       | C | † |     |              | X |     |                      |   |     |            |   |

| C | Committee Chairperson |

| † | Financial Expert |

Audit Committee The Audit Committee’s main function is to oversee our accounting and financial reporting processes and the audits of our financial statements. This committee’s responsibilities include, among other things:

| • |     | appointing our independent registered public accounting firm; |

| • |     | evaluating the qualifications, independence and performance of our independent registered public accounting firm; |

| • |     | approving the audit and non-audit services to be performed by our independent registered public accounting firm; |

| • |     | reviewing the design, implementation, adequacy and effectiveness of our internal accounting controls and our critical accounting policies; |

| • |     | discussing with management and the independent registered public accounting firm the results of our annual audit and the review of our quarterly unaudited financial statements; |

| • |     | reviewing, overseeing and monitoring the integrity of our financial statements and our compliance with legal and regulatory requirements as they relate to financial statements or accounting matters; |

| • |     | reviewing on a periodic basis, or as appropriate, any investment policy and recommending to the Board any changes to such investment policy; |

| • |     | reviewing with management and our auditors any earnings announcements and other public announcements regarding our results of operations; |

19

| • |     | preparing the report that the SEC requires in our annual proxy statement; |

| • |     | discussing the Company’s policies with respect to risk assessment and risk management, including with respect to cybersecurity; |

| • |     | reviewing and approving any related party transactions and reviewing and monitoring compliance with our code of conduct and ethics; and |

| • |     | reviewing and evaluating, at least annually, the performance of the Audit Committee and its members including compliance of the Audit Committee with its charter. |

The members of our Audit Committee are Mr. Verjee, Mr. More and Dr. McCracken. Mr. Verjee serves as the Chairperson of the Audit Committee. All members of our Audit Committee meet the requirements for financial literacy under the applicable rules and regulations of the SEC and Nasdaq.